13F reference period
Q2 2026
Security Snapshot
NextCure, Inc. - Common Stock, $0.001 par value per share (NXTC) Institutional Ownership
CUSIP: 65343E207
13F Institutional Holders and Ownership History from Q3 2025 to Q3 2026
Institutions Reporting
30
Shares (Excl. Options)
1.74M
Full value: 1,735,135 · shares · 30 Jun 2026Price
$1.60
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Symbol
- NXTC on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 1,735,135
- Total 13F value
- $2,777,967
- Portfolio coverage rank
- 0%
- Share change
- -434,319
- Value change
- -$6,043,586
- Number of holders
- 30
- Shares outstanding
- 4,595,970
- SEC-reported price per share
- $6.28
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- NXTC - NextCure, Inc. - Common Stock, $0.001 par value per share is tracked under CUSIP 65343E207.
- 30 institutions reported positions in Q2 2026.
- 9 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 26 to 30 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$22.95M
Full value: $22,952,232 · USD · 31 Mar 2026.$2.78M
Full value: $2,777,967 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 30 institutions filings for Q2 2026.
Security key
65343E207
13F reference period
Q2 2026
13F holders
30
13D/G owners
9
CIK / CUSIP context first
Open Q2 2026 holders
NXTC full holder history
NextCure, Inc. SEC filings
NextCure, Inc. company facts
NextCure, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 65343E207:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
9
Security
NXTC
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 16% | $1,574,873 | 722,419 | ADAR1 Capital Management, LLC | 31 Jul 2026 | |||
| Ikarian Capital, LLC | 10% | 0% | $1,095,825 | +$304,409 | 502,672 | +38% | Ikarian Capital, LLC | 30 Jun 2026 |
| JP Sailing Capital Ltd | 9.9% | $2,206,755 | 455,001 | JP Sailing Capital Ltd | 30 Sep 2026 | |||
| Simcere Zaiming, Inc. | 13% | $1,696,566 | 338,636 | Simcere Zaiming, Inc. | 20 Jun 2025 | |||
| Adage Capital Management, L.P. | 7.7% | $604,300 | 277,202 | Adage Capital Management, L.P. | 30 Jun 2026 | |||
| Affinity Asset Advisors, LLC | 6.4% | -36% | $597,479 | -$162,484 | 274,073 | -21% | Affinity Asset Advisors, LLC | 30 Jun 2026 |
| Sofinnova Venture Partners IX, L.P. | 7.1% | $2,947,939 | 222,654 | Sofinnova Venture Partners IX, L.P. ("SVP IX") | 19 Dec 2025 | |||
| SILVERARC CAPITAL MANAGEMENT, LLC | 5% | $2,286,980 | 176,057 | SilverArc Capital Management, LLC | 31 Dec 2025 | |||
| Squadron Capital Management LLC | 1.6% | -83% | $140,532 | -$450,525 | 64,464 | -76% | Squadron Master Fund LP | 30 Jun 2026 |
As of 30 Jun 2026,
30
institutional investors reported holding
shares of
NextCure, Inc. - Common Stock, $0.001 par value per share (NXTC).
This represents
38%
of the company’s total
outstanding shares.
1.74M
Full value: 1,735,135 · shares · 30 Jun 20264.6M
Full value: 4,595,970 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
38%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | 6.3% | 288,303 | +21% | 0.08% | $461,284 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6% | 277,202 | 0% | $443,523 | |
| Sofinnova Investments, Inc. | 4.8% | 222,654 | 0% | 0.02% | $356,246 |
| RENAISSANCE TECHNOLOGIES LLC | 3.7% | 171,202 | +183% | 0% | $273,923 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.4% | 156,842 | -2.3% | 0% | $250,947 |
| MILLENNIUM MANAGEMENT LLC | 1.9% | 88,112 | 0% | $140,979 | |
| BOOTHBAY FUND MANAGEMENT, LLC | 1.8% | 84,687 | +22% | 0% | $135,499 |
| Squadron Capital Management LLC | 1.4% | 64,464 | -76% | 0.04% | $103,142 |
| Verdad Advisers, LP | 1.3% | 60,451 | +41% | 0.09% | $96,722 |
| Pfizer Inc | 0.96% | 44,347 | -71% | 0.04% | $72,967 |
| Affinity Asset Advisors, LLC | 0.91% | 41,960 | -83% | 0% | $67,136 |
| BlackRock, Inc. | 0.81% | 37,348 | +34% | 0% | $59,757 |
| HRT FINANCIAL LP | 0.79% | 36,450 | 0% | $58,000 | |
| JANE STREET GROUP, LLC | 0.71% | 32,725 | 0% | $52,360 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.65% | 29,905 | -3.8% | 0% | $47,855 |
| CARDIFF PARK ADVISORS, LLC | 0.48% | 21,833 | 0% | 0% | $34,933 |
| ACADIAN ASSET MANAGEMENT LLC | 0.41% | 18,982 | 0% | 0% | $30,000 |
| VANGUARD FIDUCIARY TRUST CO | 0.35% | 16,134 | +0.74% | 0% | $25,814 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 0.27% | 12,500 | 0% | $20,000 | |
| Virtu Financial LLC | 0.24% | 10,991 | 0% | $18,000 | |
| DIADEMA PARTNERS LP | 0.17% | 7,742 | 0% | $12,387 | |
| BARCLAYS PLC | 0.12% | 5,726 | +1.8% | 0% | $9,162 |
| Persistent Asset Partners Ltd | 0.04% | 1,981 | 0% | $3,170 | |
| Tower Research Capital LLC (TRC) | 0.04% | 1,738 | 0% | $2,781 | |
| UBS Group AG | 0.01% | 594 | +76% | 0% | $951 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
5
Headline period
Q2 2026
Rows shown
1-5 of 5
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 1,000 | $5,010 | +$4,910 | $5.01 | 1 |
| 2026 Q2 | 1,735,135 | $2,777,967 | -$6,043,586 | $1.60 | 30 |
| 2026 Q1 | 2,169,454 | $22,952,232 | +$1,884,758 | $10.68 | 26 |
| 2025 Q4 | 1,897,561 | $26,925,657 | +$12,224,139 | $14.19 | 24 |
| 2025 Q3 | 836,243 | $4,898,495 | +$4,898,307 | $5.86 | 16 |